Skip to main content

Table 2 Chi-square results: recurrent freebayes mutations expanded beyond tumor suppressors and oncogenes

From: Germline genetic biomarkers to stratify patients for personalized radiation treatment

  1. Patients in Group A experienced a higher CTCAE grade for late dysphagia compared to their early dysphagia. Patients in Group B experienced the same or lower CTCAE grade for early and late dysphagia. The effect value > 1 is the odds ratio for increased proportion of germline variants in Group A